Vanguard Capital Management’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.7M Sell
7,144,758
-82,260
-1% -$232K ﹤0.01% 2592
2026
Q2
$22.5M Buy
7,227,018
+3,198,027
+79% +$10.5M ﹤0.01% 2382
2026
Q1
$10.8M Buy
+4,028,991
New +$11.2M ﹤0.01% 2689

Other funds holding CABA

Vanguard Capital Management's CABA Position: Q3 2026 in Review

Vanguard Capital Management reduced its Cabaletta Bio (CABA) stake by 1.1% in Q3 2026, selling an estimated $232K and leaving 7,144,758 shares worth $13.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2592.

Vanguard Capital Management first reported a position in CABA in Q1 2026 and has held it in 3 quarters since. The position peaked at $22.5M in Q2 2026. 163 funds tracked by Wall St. Rank hold CABA as of Q3 2026.

  • Vanguard Capital Management held 7,144,758 shares of Cabaletta Bio worth $13.7M as of Q3 2026.
  • Vanguard Capital Management sold 82,260 Cabaletta Bio shares in Q3 2026, an estimated $232K.
  • Cabaletta Bio made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2592 holding.
  • Vanguard Capital Management first reported a position in Cabaletta Bio in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Cabaletta Bio position peaked at $22.5M in Q2 2026.
  • 163 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.